TNPSC Thervupettagam

Dexamethasone

June 20 , 2020 1494 days 955 0
  • It is "the first drug to be shown to improve survival in COVID-19". 
  • It is a steroid drug typically used to reduce inflammation.
  • It is used to treat conditions such as arthritis, blood/hormone/immune system disorders, allergic reactions, certain skin and eye conditions, breathing problems, certain bowel disorders, and certain cancers.
  • It is also used as a test for an adrenal gland disorder (Cushing's syndrome).
  • The observation was based on a clinical trial called RECOVERY (Randomised Evaluation of COVid-19 therapy) by the University of Oxford in England.
  • The drug is manufactured in India by Cadila Healthcare or Zydus Cadila of Ahmedabad. 

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories